Parallel Advisors, LLC: TEM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Parallel Advisors, LLC on TEM, newest first. How the timeline and the estimate are built.
Parallel Advisors, LLC held 739 TEM shares at 2026-06-30 per its 13F-HR filed 2026-08-05.
the latest 13F is the newest step
- period ended2026-06-3013F 739 sharesChange vs previous 13F +641 shares
<0.01% of the 13F portfolio, value $42,810.
13F-HR 0001690010-26-000005 filed by Parallel Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F/A 98 sharesChange vs previous 13F +52 shares
<0.01% of the 13F portfolio, value $4,432.
13F-HR/A 0001690010-26-000004 filed by Parallel Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 46 sharesChange vs previous 13F +35 shares
<0.01% of the 13F portfolio, value $2,766.
13F-HR 0001690010-26-000001 filed by Parallel Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 11 sharesChange vs previous 13F +1 shares
<0.01% of the 13F portfolio, value $955.
13F-HR 0001690010-25-000009 filed by Parallel Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 10 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $625.
13F-HR 0001690010-25-000005 filed by Parallel Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 10 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $492.
13F-HR 0001690010-25-000004 filed by Parallel Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).